USA Narcolepsy Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Narcolepsy is a neurological disorder that affects the control of sleep and wakefulness. People with narcolepsy experience excessive daytime sleepiness and intermittent, uncontrollable episodes of falling asleep during the daytime. These sudden sleep attacks may occur during any type of activity at any time of the day.

    People with narcolepsy can be substantially helped, but not cured. Treatment is tailored to the individual, based on symptoms and therapeutic response. The time required to achieve optimal control of symptoms is highly variable and may take several months or longer. Medication adjustments are frequently necessary, and complete control of symptoms is seldom possible. While oral medications are the mainstay of formal narcolepsy treatment, lifestyle changes are also important.

    This report offers an overview of the market trends, drivers, and barriers with respect to the USA Narcolepsy market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Narcolepsy market. Detailed analysis of key players, along with key growth strategies adopted by Narcolepsy industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Shire (Republic of Ireland)

    • Shionogi Inc (US)

    • Ligand Pharmaceuticals, Inc (US)

    • Teva Pharmaceutical Industries Ltd (Israel)

    • Novartis AG (Switzerland)

    • Jazz Pharmaceuticals plc (Republic of Ireland)

    • Arena Pharmaceuticals, Inc (US)

    • Mylan NV (US)

    • Graymark Healthcare, Inc (US)

    • BIOPROJET (Paris)

    By Type:

    • Polysomnogram

    • Multiple Sleep Latency Test

    By End-User:

    • Hospitals

    • Retail Pharmacies

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Narcolepsy Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Narcolepsy Market Size and Growth Rate of Polysomnogram from 2016 to 2027

      • 1.3.2 USA Narcolepsy Market Size and Growth Rate of Multiple Sleep Latency Test from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Narcolepsy Market Size and Growth Rate of Hospitals from 2016 to 2027

      • 1.4.2 USA Narcolepsy Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Narcolepsy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Narcolepsy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Narcolepsy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Narcolepsy Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Narcolepsy Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Narcolepsy by Major Types

      • 3.4.1 Market Size and Growth Rate of Polysomnogram

      • 3.4.2 Market Size and Growth Rate of Multiple Sleep Latency Test

    4 Segmentation of Narcolepsy Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Narcolepsy by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Narcolepsy in Hospitals

      • 4.4.2 Market Size and Growth Rate of Narcolepsy in Retail Pharmacies

    5 Market Analysis by Regions

    • 5.1 USA Narcolepsy Production Analysis by Regions

    • 5.2 USA Narcolepsy Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Narcolepsy Landscape Analysis

    • 6.1 West USA Narcolepsy Landscape Analysis by Major Types

    • 6.2 West USA Narcolepsy Landscape Analysis by Major End-Users

    7 South USA Narcolepsy Landscape Analysis

    • 7.1 South USA Narcolepsy Landscape Analysis by Major Types

    • 7.2 South USA Narcolepsy Landscape Analysis by Major End-Users

    8 Middle West USA Narcolepsy Landscape Analysis

    • 8.1 Middle West USA Narcolepsy Landscape Analysis by Major Types

    • 8.2 Middle West USA Narcolepsy Landscape Analysis by Major End-Users

    9 Northeast USA Narcolepsy Landscape Analysis

    • 9.1 Northeast USA Narcolepsy Landscape Analysis by Major Types

    • 9.2 Northeast USA Narcolepsy Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Shire (Republic of Ireland)

        • 10.1.1 Shire (Republic of Ireland) Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Shionogi Inc (US)

        • 10.2.1 Shionogi Inc (US) Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Ligand Pharmaceuticals, Inc (US)

        • 10.3.1 Ligand Pharmaceuticals, Inc (US) Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Teva Pharmaceutical Industries Ltd (Israel)

        • 10.4.1 Teva Pharmaceutical Industries Ltd (Israel) Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Novartis AG (Switzerland)

        • 10.5.1 Novartis AG (Switzerland) Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Jazz Pharmaceuticals plc (Republic of Ireland)

        • 10.6.1 Jazz Pharmaceuticals plc (Republic of Ireland) Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Arena Pharmaceuticals, Inc (US)

        • 10.7.1 Arena Pharmaceuticals, Inc (US) Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Mylan NV (US)

        • 10.8.1 Mylan NV (US) Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Graymark Healthcare, Inc (US)

        • 10.9.1 Graymark Healthcare, Inc (US) Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 BIOPROJET (Paris)

        • 10.10.1 BIOPROJET (Paris) Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Narcolepsy Market Size and Growth Rate of Polysomnogram from 2016 to 2027

    • Figure USA Narcolepsy Market Size and Growth Rate of Multiple Sleep Latency Test from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Narcolepsy Market Size and Growth Rate of Hospitals from 2016 to 2027

    • Figure USA Narcolepsy Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Narcolepsy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Narcolepsy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Narcolepsy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Narcolepsy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Narcolepsy Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Narcolepsy

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Narcolepsy by Different Types from 2016 to 2027

    • Table Consumption Share of Narcolepsy by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Polysomnogram

    • Figure Market Size and Growth Rate of Multiple Sleep Latency Test

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Narcolepsy by Different End-Users from 2016 to 2027

    • Table Consumption Share of Narcolepsy by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Retail Pharmacies

    • Table USA Narcolepsy Production by Regions

    • Table USA Narcolepsy Production Share by Regions

    • Figure USA Narcolepsy Production Share by Regions in 2016

    • Figure USA Narcolepsy Production Share by Regions in 2021

    • Figure USA Narcolepsy Production Share by Regions in 2027

    • Table USA Narcolepsy Consumption by Regions

    • Table USA Narcolepsy Consumption Share by Regions

    • Figure USA Narcolepsy Consumption Share by Regions in 2016

    • Figure USA Narcolepsy Consumption Share by Regions in 2021

    • Figure USA Narcolepsy Consumption Share by Regions in 2027

    • Table West USA Narcolepsy Consumption by Types from 2016 to 2027

    • Table West USA Narcolepsy Consumption Share by Types from 2016 to 2027

    • Figure West USA Narcolepsy Consumption Share by Types in 2016

    • Figure West USA Narcolepsy Consumption Share by Types in 2021

    • Figure West USA Narcolepsy Consumption Share by Types in 2027

    • Table West USA Narcolepsy Consumption by End-Users from 2016 to 2027

    • Table West USA Narcolepsy Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Narcolepsy Consumption Share by End-Users in 2016

    • Figure West USA Narcolepsy Consumption Share by End-Users in 2021

    • Figure West USA Narcolepsy Consumption Share by End-Users in 2027

    • Table South USA Narcolepsy Consumption by Types from 2016 to 2027

    • Table South USA Narcolepsy Consumption Share by Types from 2016 to 2027

    • Figure South USA Narcolepsy Consumption Share by Types in 2016

    • Figure South USA Narcolepsy Consumption Share by Types in 2021

    • Figure South USA Narcolepsy Consumption Share by Types in 2027

    • Table South USA Narcolepsy Consumption by End-Users from 2016 to 2027

    • Table South USA Narcolepsy Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Narcolepsy Consumption Share by End-Users in 2016

    • Figure South USA Narcolepsy Consumption Share by End-Users in 2021

    • Figure South USA Narcolepsy Consumption Share by End-Users in 2027

    • Table Middle West USA Narcolepsy Consumption by Types from 2016 to 2027

    • Table Middle West USA Narcolepsy Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Narcolepsy Consumption Share by Types in 2016

    • Figure Middle West USA Narcolepsy Consumption Share by Types in 2021

    • Figure Middle West USA Narcolepsy Consumption Share by Types in 2027

    • Table Middle West USA Narcolepsy Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Narcolepsy Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Narcolepsy Consumption Share by End-Users in 2016

    • Figure Middle West USA Narcolepsy Consumption Share by End-Users in 2021

    • Figure Middle West USA Narcolepsy Consumption Share by End-Users in 2027

    • Table Northeast USA Narcolepsy Consumption by Types from 2016 to 2027

    • Table Northeast USA Narcolepsy Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Narcolepsy Consumption Share by Types in 2016

    • Figure Northeast USA Narcolepsy Consumption Share by Types in 2021

    • Figure Northeast USA Narcolepsy Consumption Share by Types in 2027

    • Table Northeast USA Narcolepsy Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Narcolepsy Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Narcolepsy Consumption Share by End-Users in 2016

    • Figure Northeast USA Narcolepsy Consumption Share by End-Users in 2021

    • Figure Northeast USA Narcolepsy Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Shire (Republic of Ireland)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shire (Republic of Ireland)

    • Figure Sales and Growth Rate Analysis of Shire (Republic of Ireland)

    • Figure Revenue and Market Share Analysis of Shire (Republic of Ireland)

    • Table Product and Service Introduction of Shire (Republic of Ireland)

    • Table Company Profile and Development Status of Shionogi Inc (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shionogi Inc (US)

    • Figure Sales and Growth Rate Analysis of Shionogi Inc (US)

    • Figure Revenue and Market Share Analysis of Shionogi Inc (US)

    • Table Product and Service Introduction of Shionogi Inc (US)

    • Table Company Profile and Development Status of Ligand Pharmaceuticals, Inc (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ligand Pharmaceuticals, Inc (US)

    • Figure Sales and Growth Rate Analysis of Ligand Pharmaceuticals, Inc (US)

    • Figure Revenue and Market Share Analysis of Ligand Pharmaceuticals, Inc (US)

    • Table Product and Service Introduction of Ligand Pharmaceuticals, Inc (US)

    • Table Company Profile and Development Status of Teva Pharmaceutical Industries Ltd (Israel)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical Industries Ltd (Israel)

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceutical Industries Ltd (Israel)

    • Figure Revenue and Market Share Analysis of Teva Pharmaceutical Industries Ltd (Israel)

    • Table Product and Service Introduction of Teva Pharmaceutical Industries Ltd (Israel)

    • Table Company Profile and Development Status of Novartis AG (Switzerland)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG (Switzerland)

    • Figure Sales and Growth Rate Analysis of Novartis AG (Switzerland)

    • Figure Revenue and Market Share Analysis of Novartis AG (Switzerland)

    • Table Product and Service Introduction of Novartis AG (Switzerland)

    • Table Company Profile and Development Status of Jazz Pharmaceuticals plc (Republic of Ireland)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jazz Pharmaceuticals plc (Republic of Ireland)

    • Figure Sales and Growth Rate Analysis of Jazz Pharmaceuticals plc (Republic of Ireland)

    • Figure Revenue and Market Share Analysis of Jazz Pharmaceuticals plc (Republic of Ireland)

    • Table Product and Service Introduction of Jazz Pharmaceuticals plc (Republic of Ireland)

    • Table Company Profile and Development Status of Arena Pharmaceuticals, Inc (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arena Pharmaceuticals, Inc (US)

    • Figure Sales and Growth Rate Analysis of Arena Pharmaceuticals, Inc (US)

    • Figure Revenue and Market Share Analysis of Arena Pharmaceuticals, Inc (US)

    • Table Product and Service Introduction of Arena Pharmaceuticals, Inc (US)

    • Table Company Profile and Development Status of Mylan NV (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan NV (US)

    • Figure Sales and Growth Rate Analysis of Mylan NV (US)

    • Figure Revenue and Market Share Analysis of Mylan NV (US)

    • Table Product and Service Introduction of Mylan NV (US)

    • Table Company Profile and Development Status of Graymark Healthcare, Inc (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Graymark Healthcare, Inc (US)

    • Figure Sales and Growth Rate Analysis of Graymark Healthcare, Inc (US)

    • Figure Revenue and Market Share Analysis of Graymark Healthcare, Inc (US)

    • Table Product and Service Introduction of Graymark Healthcare, Inc (US)

    • Table Company Profile and Development Status of BIOPROJET (Paris)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BIOPROJET (Paris)

    • Figure Sales and Growth Rate Analysis of BIOPROJET (Paris)

    • Figure Revenue and Market Share Analysis of BIOPROJET (Paris)

    • Table Product and Service Introduction of BIOPROJET (Paris)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.